| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/04/2008 | US20080213881 Expression vector coding nucleotide sequences comprising novel cytokine upregulated by interleukin-9 for use in treatment and prevention of cell hodgkin's disease |
| 09/04/2008 | US20080213880 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 09/04/2008 | US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| 09/04/2008 | US20080213878 Novel human membrane proteins and polynucleotides encoding the same |
| 09/04/2008 | US20080213871 Expression vector comprising nucleotide sequences coding short interfering RNA for use in increasing cellulose production in plants and drecreasing cost of pretreating biofuels |
| 09/04/2008 | US20080213861 Using targeted gene expression inhibition to treat and prevent viral infection |
| 09/04/2008 | US20080213859 Methods for the Reduction of Stutter in Microsatellite Amplification |
| 09/04/2008 | US20080213852 Nucleotide sequences coding sugar transporter and/or sugar alcohol transporter for use in enhanced fermentation of vitamin c |
| 09/04/2008 | US20080213847 Using modified saccharomyces as biorecators for fermentation of farnesol, nerolidol and/or geranylgeraniol |
| 09/04/2008 | US20080213843 Heat stable glycoamylase for use in producing ethanol for fuel and/or beverages; sweetener production |
| 09/04/2008 | US20080213842 Kit for synthesizing polynucleotides |
| 09/04/2008 | US20080213839 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 09/04/2008 | US20080213838 Expression vector comprising nucleotide sequences coding aminopeptidase A (APA) protein for use in prvention and treatment of preclampsia |
| 09/04/2008 | US20080213837 Apo-3 ligand polypeptide |
| 09/04/2008 | US20080213836 Modified enteropeptidase protein |
| 09/04/2008 | US20080213835 Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same |
| 09/04/2008 | US20080213834 Gsk3 ligands and polynucleotides encoding gsk3 ligands |
| 09/04/2008 | US20080213832 Sesquiterpene synthases and methods of use |
| 09/04/2008 | US20080213831 Human cytokine receptor |
| 09/04/2008 | US20080213829 Expression vector comprising nucleotide sequences coding glutamine synthetases for enhancing biosynthesis of polypeptides |
| 09/04/2008 | US20080213813 Histone deacetylase inhibitor and use thereof |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213798 Novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegans |
| 09/04/2008 | US20080213795 Plasmodium epitope polypeptide for use in treatment and prevention malarial infection |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213790 Method for synthesizing polynucleotides |
| 09/04/2008 | US20080213789 Detecting DNA 5'-methylation at cytosine residue of a CpG site via specific primer extension |
| 09/04/2008 | US20080213788 Using presence of amino acid substitution in dehydratase as evaluative tool in prediciting fungicidal resistance in rice crops |
| 09/04/2008 | US20080213786 Using lectin modulators as treatments for cell proliferative and inflammatory disorders |
| 09/04/2008 | US20080213779 Using variation in NLR family, pyrin domain containing 7 (NALP7) gene as evaluative tool in diagnosis/prognosis of gestation disorders |
| 09/04/2008 | US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213764 Human Protooncogene and Protein Encoded Therein |
| 09/04/2008 | US20080213763 For diagnosing cancers including leukemia, uterine cancer, lymphoma, colon cancer, lung cancer, and skin cancer |
| 09/04/2008 | US20080213760 Compositions and methods for protein isolation |
| 09/04/2008 | US20080213759 Novel Angiogenesis Inhibitor |
| 09/04/2008 | US20080213754 Method of Amplifying Atp and Use Thereof |
| 09/04/2008 | US20080213750 HCV Variants and Related Methods |
| 09/04/2008 | US20080213694 Acid generator mixture is a diphenyl iodinium mesylate, tosylate or perfluorobutylsulfonate salt, a nonionic fluoroaliphatic polymer ester surfactant and N-methylpyrrolidone; solid phase synthesis of DNA, RNA, peptide nucleic acids, locked nucleic acids, or proteins for chips; photolithography |
| 09/04/2008 | US20080213457 Generation of plants with altered protein, fiber, or oil content |
| 09/04/2008 | US20080213454 Genetic transformation of apple without use of a selectable marker |
| 09/04/2008 | US20080213430 nucleic acid constructs, vectors, and host cells; detergents; transgenic plants; animal feeds |
| 09/04/2008 | US20080213426 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 09/04/2008 | US20080213387 Isolated cytotrophoblast stem cell expresses HLA-G and HLA class I antigen; cytokeratin 7; stage specific embryonic antigen 1; human placental lactogen; caudal related homeobox; vimentin; Cd9 marker; chimeric cell for the modulation of cell/tissue rejection in transplantation therapy |
| 09/04/2008 | US20080213340 Alzheimer's prevention oral vaccines; inserting expression vector into agrobacterium and culturing |
| 09/04/2008 | US20080213314 Combined dna vaccine and biological modifiers for cancer therapy |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213309 Multi-antigenic alphavirus replicon particles and methods |
| 09/04/2008 | US20080213303 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/04/2008 | US20080213295 Estrogen receptor polypeptide which induces immune respone; for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 09/04/2008 | US20080213294 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 09/04/2008 | US20080213292 Soluble And Stabilized Trimeric Form Of Gp41 Polypeptides |
| 09/04/2008 | US20080213290 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 09/04/2008 | US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders |
| 09/04/2008 | US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/04/2008 | US20080213284 Receptor binding polypeptides |
| 09/04/2008 | US20080213277 Peptide hormone specific monoclonal antibody for use in diagnosis, prognosis, prevention and treatment of blood, cell proliferative, inflammatory, kidney and liver disorders |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213265 Human cytomegalovirus neutralising antibodies and use thereof |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213256 Less Immunogenic Binding Molecules |
| 09/04/2008 | US20080213254 Immunoglobulin capable of linking immunoreceptor tyrosine-based activation motif (ITAM) with immunoreceptor tyrosine-based inhibition motif (ITIM) for use in treatment of allergic disorders; gene therapy |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213233 Using vector transfer to preferential gene sequence into cells; treating nervous system, cell proliferative, muscle, kidney and pancreatic disorders |
| 09/04/2008 | US20080213223 Using virus-ligand complex to specifically bind and target cancer cells for destruction; gene therapy |
| 09/04/2008 | US20080213222 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213220 Adenovirus vector comprising progression elevated gene-3 (PEG-3) regulatory sequences and E1A tumor suppressor gene for use in targeted destruction of cancer cells; antiproliferative agents |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | US20080213182 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
| 09/04/2008 | US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions |
| 09/04/2008 | US20080213177 Nanoparticles Comprising Rna Ligands |
| 09/04/2008 | US20080210631 Purified enzyme having an activity in the MTBE degradation path; novel bacterial strain Mycobacterium austroafricanum; bioremediation of water contamination |
| 09/04/2008 | DE102007010785A1 Use of superoxide dismutases to cleave and/or remove Amadori and/or Maillard products, especially as components of detergent, cosmetic or pharmaceutical products |
| 09/04/2008 | DE102007008890A1 Nukleinsäure, die für eine pflanzliche Adenosin-Nukleosidase kodiert Nucleic acid encoding a plant adenosine nucleosidase |
| 09/04/2008 | CA2699418A1 Composition and methods for modulating cell proliferation and cell death |
| 09/04/2008 | CA2681662A1 Method for increasing transformation efficiency in plants, comprising coculture step for culturing plant tissue with coculture medium containing 3,6-dichloro-o-anisic acid |
| 09/04/2008 | CA2679532A1 Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them |
| 09/04/2008 | CA2679503A1 Nitrilases, nucleic acids encoding them and methods for making and using them |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | CA2679077A1 Plants having enhanced yield-related traits and a method for making the same |
| 09/04/2008 | CA2678774A1 Treatment of diseases characterized by inflammation |
| 09/04/2008 | CA2678603A1 Chloroplast transit peptides for efficient targeting of dmo and uses thereof |
| 09/04/2008 | CA2678450A1 Planar electroporation apparatus and method |
| 09/04/2008 | CA2677771A1 Method for cloning cognate antibodies |
| 09/04/2008 | CA2677075A1 Method for activation of helper t cell and composition for use in the method |
| 09/03/2008 | EP1964947A1 Mask set for microarray, method of fabricating mask set, and method of fabricating microarray using mask set |
| 09/03/2008 | EP1964932A2 Directed evolution method |
| 09/03/2008 | EP1964922A1 Improvement of protein production |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964920A1 Instrument and method for nucleic acid isolation |
| 09/03/2008 | EP1964919A1 Method for improvement in efficiency of transformation using powder |
| 09/03/2008 | EP1964917A1 Novel lipase |
| 09/03/2008 | EP1964916A1 Multi-purpose acylation catalayst and use thereof |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964851A1 Treatment of micro-organism infection |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |